ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 72 filers reported holding ANTARES PHARMA INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $6,571,000 | +38.7% | 2,820,119 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $4,738,000 | +60.0% | 2,820,119 | 0.0% | 0.00% | – |
Q2 2016 | $2,961,000 | -17.0% | 2,820,119 | -31.3% | 0.00% | -100.0% |
Q1 2016 | $3,569,000 | -28.6% | 4,102,321 | -0.7% | 0.00% | 0.0% |
Q4 2015 | $5,000,000 | -29.4% | 4,131,833 | -0.9% | 0.00% | 0.0% |
Q3 2015 | $7,087,000 | -17.0% | 4,169,091 | +1.6% | 0.00% | 0.0% |
Q2 2015 | $8,538,000 | -20.7% | 4,104,637 | +3.4% | 0.00% | -50.0% |
Q1 2015 | $10,763,000 | +5.4% | 3,971,418 | -0.1% | 0.00% | 0.0% |
Q4 2014 | $10,215,000 | +37.0% | 3,974,609 | -2.4% | 0.00% | +100.0% |
Q3 2014 | $7,456,000 | -30.1% | 4,074,358 | +2.0% | 0.00% | -50.0% |
Q2 2014 | $10,661,000 | -25.0% | 3,992,827 | -1.7% | 0.00% | 0.0% |
Q1 2014 | $14,216,000 | -16.3% | 4,061,785 | +6.9% | 0.00% | -33.3% |
Q4 2013 | $16,984,000 | +13.1% | 3,798,781 | +2.7% | 0.00% | 0.0% |
Q3 2013 | $15,019,000 | +4.1% | 3,699,209 | +6.6% | 0.00% | 0.0% |
Q2 2013 | $14,430,000 | – | 3,468,699 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 500,000 | $2,055,000 | 4.58% |
Centric Wealth Management | 3,337,449 | $13,717,000 | 3.92% |
Sargent Investment Group, LLC | 3,599,580 | $14,794,000 | 3.90% |
Rubric Capital Management LP | 8,722,647 | $35,850,000 | 2.09% |
PERKINS CAPITAL MANAGEMENT INC | 542,283 | $2,229,000 | 1.29% |
ORACLE INVESTMENT MANAGEMENT INC | 1,900,000 | $7,809,000 | 1.17% |
Venator Capital Management Ltd. | 550,000 | $2,624,000 | 0.89% |
LEVEL FOUR FINANCIAL, LLC | 120,000 | $493,000 | 0.23% |
ALGERT GLOBAL LLC | 147,616 | $607,000 | 0.19% |
Brown Advisory Securities, LLC | 275,000 | $1,130,000 | 0.19% |